Genetic Divergence of Vibrio vulnificus Clinical Isolates with Mild to Severe Outcomes

Vibrio vulnificus is an aquatic pathogen that is capable of causing severe disease in humans. Previous studies have suggested that pathogenic isolates were restricted to certain phylogenetic lineages and possibly toxinotype. ABSTRACT The marine bacterium Vibrio vulnificus infects humans via food or water contamination, leading to serious manifestations, including gastroenteritis, wound infections, and septic shock. Previous studies suggest phylogenetic Lineage 1 isolates with the vcgC allele of the vcg gene cause human infections, whereas Lineage 2 isolates with the vcgE allele are less pathogenic. Mouse studies suggest that some variants of the primary toxin could drive more serious infections. A collection of 109 V. vulnificus United States human clinical isolates from 2001 to 2019 with paired clinical outcome data were assembled. The isolates underwent whole-genome sequencing, multilocus-sequence phylogenetic analysis, and toxinotype analysis of the multifunctional autoprocessing repeats-in-toxin (MARTX) toxin. In contrast to prior reports, clinical isolates were equally distributed between lineages. We found no correlation between phylogenetic lineage or MARTX toxinotype and disease severity. Infections caused by isolates in Lineage 1 demonstrated a borderline statistically significant higher mortality. Lineage 1 isolates had a trend toward a higher proportion of M-type MARTX toxins compared with Lineage 2, although this was not statistically significant. IMPORTANCE Vibrio vulnificus is an aquatic pathogen that is capable of causing severe disease in humans. Previous studies have suggested that pathogenic isolates were restricted to certain phylogenetic lineages and possibly toxinotype. Our study demonstrated that phylogenetic lineage and multifunctional autoprocessing repeats-in-toxin (MARTX) toxinotype do not predict severity of infection. V. vulnificus strains capable of causing severe human disease are not concentrated in Lineage 1 but are genetically diverse. Thus, food surveillance based on lineage type or toxinotype may not be an appropriate intervention measure to control this rare but serious infection.

[1]  A. Godzik,et al.  Actin Cross-Linking Effector Domain of the Vibrio vulnificus F-Type MARTX Toxin Dominates Disease Progression During Intestinal Infection , 2022, Infection and immunity.

[2]  Jessica L Jones,et al.  Biochemical and Virulence Characterization of Vibrio vulnificus Isolates From Clinical and Environmental Sources , 2021, Frontiers in Cellular and Infection Microbiology.

[3]  Karla J. F. Satchell,et al.  The Vibrio cholerae MARTX toxin silences the inflammatory response to cytoskeletal damage before inducing actin cytoskeleton collapse , 2020, Science Signaling.

[4]  Olga Chernomor,et al.  IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic Era , 2019, bioRxiv.

[5]  P. Bork,et al.  Interactive Tree Of Life (iTOL) v4: recent updates and new developments , 2019, Nucleic Acids Res..

[6]  F. Rodríguez-Valera,et al.  Evolutionary Model of Cluster Divergence of the Emergent Marine Pathogen Vibrio vulnificus: From Genotype to Ecotype , 2019, mBio.

[7]  Karla J. F. Satchell,et al.  RRSP and RID Effector Domains Dominate the Virulence Impact of Vibrio vulnificus MARTX Toxin , 2018, The Journal of infectious diseases.

[8]  B. Kim.  The Modes of Action of MARTX Toxin Effector Domains , 2018, Toxins.

[9]  Shatavia S. Morrison,et al.  Phylogeny of Vibrio vulnificus from the Analysis of the Core-Genome: Implications for Intra-Species Taxonomy , 2018, Front. Microbiol..

[10]  Karla J. F. Satchell,et al.  Coordinated delivery and function of bacterial MARTX toxin effectors , 2018, Molecular microbiology.

[11]  Karla J. F. Satchell,et al.  Variable Virulence of Biotype 3 Vibrio vulnificus due to MARTX Toxin Effector Domain Composition , 2017, mSphere.

[12]  A. von Haeseler,et al.  UFBoot2: Improving the Ultrafast Bootstrap Approximation , 2017, bioRxiv.

[13]  J. Oliver,et al.  Different abundance and correlational patterns exist between total and presumed pathogenic Vibrio vulnificus and V. parahaemolyticus in shellfish and waters along the North Carolina coast , 2017, FEMS microbiology ecology.

[14]  Thomas K. F. Wong,et al.  ModelFinder: Fast Model Selection for Accurate Phylogenetic Estimates , 2017, Nature Methods.

[15]  Karla J. F. Satchell,et al.  Vibrio vulnificus: From Oyster Colonist to Human Pathogen , 2017, PLoS pathogens.

[16]  Rida Assaf,et al.  Improvements to PATRIC, the all-bacterial Bioinformatics Database and Analysis Resource Center , 2016, Nucleic Acids Res..

[17]  Mel S. Lee,et al.  Distribution of Fatal Vibrio Vulnificus Necrotizing Skin and Soft-Tissue Infections , 2016, Medicine.

[18]  Karla J. F. Satchell,et al.  MARTX toxins as effector delivery platforms. , 2015, Pathogens and disease.

[19]  Hainv Gao,et al.  Correlations between Clinical Features and Mortality in Patients with Vibrio vulnificus Infection , 2015, PloS one.

[20]  Fangfang Xia,et al.  RASTtk: A modular and extensible implementation of the RAST algorithm for building custom annotation pipelines and annotating batches of genomes , 2015, Scientific Reports.

[21]  Björn Usadel,et al.  Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..

[22]  Derrick E. Wood,et al.  Kraken: ultrafast metagenomic sequence classification using exact alignments , 2014, Genome Biology.

[23]  R. Dieckmann,et al.  Genotypic Diversity and Virulence Characteristics of Clinical and Environmental Vibrio vulnificus Isolates from the Baltic Sea Region , 2013, Applied and Environmental Microbiology.

[24]  K. Katoh,et al.  MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability , 2013, Molecular biology and evolution.

[25]  M. Iwamoto,et al.  Pre-existing medical conditions associated with Vibrio vulnificus septicaemia , 2013, Epidemiology and Infection.

[26]  D. Vugia,et al.  Increasing rates of vibriosis in the United States, 1996-2010: review of surveillance data from 2 systems. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  Sergey I. Nikolenko,et al.  SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing , 2012, J. Comput. Biol..

[28]  Keith A. Jolley,et al.  Ribosomal multilocus sequence typing: universal characterization of bacteria from domain to strain , 2012, Microbiology.

[29]  Karla J. F. Satchell,et al.  Additive Function of Vibrio vulnificus MARTXVv and VvhA Cytolysins Promotes Rapid Growth and Epithelial Tissue Necrosis During Intestinal Infection , 2012, PLoS pathogens.

[30]  B. Ge,et al.  Detecting Potentially Virulent Vibrio vulnificus Strains in Raw Oysters by Quantitative Loop-Mediated Isothermal Amplification , 2011, Applied and Environmental Microbiology.

[31]  Karla J. F. Satchell,et al.  Vibrio vulnificus rtxA1 gene recombination generates toxin variants with altered potency during intestinal infection , 2011, Proceedings of the National Academy of Sciences.

[32]  C. Garvan,et al.  Genotype Is Correlated with but Does Not Predict Virulence of Vibrio vulnificus Biotype 1 in Subcutaneously Inoculated, Iron Dextran-Treated Mice , 2011, Infection and Immunity.

[33]  F. González-Candelas,et al.  Domain Organization and Evolution of Multifunctional Autoprocessing Repeats-in-Toxin (MARTX) Toxin in Vibrio vulnificus , 2010, Applied and Environmental Microbiology.

[34]  Brandon Walts,et al.  SOLiD sequencing of four Vibrio vulnificus genomes enables comparative genomic analysis and identification of candidate clade-specific virulence genes , 2010, BMC Genomics.

[35]  O. Gascuel,et al.  New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. , 2010, Systematic biology.

[36]  K. Ohshige,et al.  Clinical features of Vibrio vulnificus infections in the coastal areas of the Ariake Sea, Japan , 2010, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[37]  Young Ran Kim,et al.  Vibrio vulnificus RTX toxin kills host cells only after contact of the bacteria with host cells , 2008, Cellular microbiology.

[38]  T. Peto,et al.  The evolution of genetic structure in the marine pathogen, Vibrio vulnificus. , 2007, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[39]  J. Oliver,et al.  Population Structures of Two Genotypes of Vibrio vulnificus in Oysters (Crassostrea virginica) and Seawater , 2007, Applied and Environmental Microbiology.

[40]  Moqing Liu,et al.  The HlyU Protein Is a Positive Regulator of rtxA1, a Gene Responsible for Cytotoxicity and Virulence in the Human Pathogen Vibrio vulnificus , 2007, Infection and Immunity.

[41]  Seung Min Kim,et al.  Identification and characterization of the Vibrio vulnificus rtxA essential for cytotoxicity in vitro and virulence in mice. , 2007, Journal of microbiology.

[42]  J. Oliver,et al.  A Rapid and Simple PCR Analysis Indicates There Are Two Subgroups of Vibrio vulnificus Which Correlate with Clinical or Environmental Isolation , 2005, Microbiology and immunology.

[43]  D. Swerdlow,et al.  Clinical, epidemiological, and microbiological features of Vibrio vulnificus biogroup 3 causing outbreaks of wound infection and bacteraemia in Israel , 1999, The Lancet.